Núria Sala

7.2k total citations · 1 hit paper
97 papers, 2.8k citations indexed

About

Núria Sala is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Núria Sala has authored 97 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 24 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Núria Sala's work include Blood Coagulation and Thrombosis Mechanisms (39 papers), Prostate Cancer Treatment and Research (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers). Núria Sala is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (39 papers), Prostate Cancer Treatment and Research (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers). Núria Sala collaborates with scholars based in Spain, United Kingdom and United States. Núria Sala's co-authors include Carlos A. González, Gabriel Capellá, Pablo Garcı́a de Frutos, J. Fontcuberta, Montserrat Borrell, Begoña Hurtado, D.N. Cooper, Sophie Gandrille, José Mateo and Theodore Rokkas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Núria Sala

94 papers receiving 2.8k citations

Hit Papers

Olaparib combined with abiraterone in patients with metas... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
    2018 281 citations Noel W. Clarke, Paweł Wiechno et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Núria Sala Spain 29 1.2k 648 616 575 476 97 2.8k
Pascale Gaussem France 38 1.2k 1.0× 771 1.2× 665 1.1× 1.1k 2.0× 355 0.7× 186 4.5k
Clifford M. Takemoto United States 27 726 0.6× 329 0.5× 226 0.4× 1.2k 2.0× 770 1.6× 78 3.3k
Mark I. Furman United States 31 1.6k 1.4× 912 1.4× 432 0.7× 360 0.6× 581 1.2× 50 4.3k
Justo Aznar Spain 30 1.1k 0.9× 405 0.6× 613 1.0× 445 0.8× 146 0.3× 121 2.9k
M Dechavanne France 31 1.3k 1.1× 529 0.8× 536 0.9× 508 0.9× 222 0.5× 137 3.1k
Bart J. Biemond Netherlands 30 2.4k 2.0× 327 0.5× 283 0.5× 982 1.7× 195 0.4× 126 3.7k
Georges E. Rivard Canada 29 1.8k 1.5× 304 0.5× 463 0.8× 705 1.2× 153 0.3× 70 2.9k
Nicole D. Zantek United States 19 766 0.7× 395 0.6× 214 0.3× 582 1.0× 518 1.1× 67 2.9k
Frederik Denorme United States 26 595 0.5× 158 0.2× 495 0.8× 632 1.1× 851 1.8× 64 2.9k
Hatem H. Salem Australia 19 1.0k 0.9× 300 0.5× 281 0.5× 454 0.8× 240 0.5× 22 1.9k

Countries citing papers authored by Núria Sala

Since Specialization
Citations

This map shows the geographic impact of Núria Sala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Sala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Sala more than expected).

Fields of papers citing papers by Núria Sala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Sala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Sala. The network helps show where Núria Sala may publish in the future.

Co-authorship network of co-authors of Núria Sala

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Sala. A scholar is included among the top collaborators of Núria Sala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Sala. Núria Sala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saad, Fred, Antoine Thiery-Vuillemin, Paweł Wiechno, et al.. (2022). Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial. The Lancet Oncology. 23(10). 1297–1307. 21 indexed citations
2.
España, Samuel, Núria Sala, Maria-Pilar Barretina-Ginesta, et al.. (2020). PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate. SHILAP Revista de lepidopterología. 2 indexed citations
3.
4.
Ochoa-de-Olza, María, Núria Sala, Josep M. Piulats, et al.. (2020). <p>PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate</p>. Cancer Management and Research. Volume 12. 10251–10260. 7 indexed citations
5.
Clarke, Noel W., Paweł Wiechno, B. Yа. Alekseev, et al.. (2018). Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Oncology. 19(7). 975–986. 281 indexed citations breakdown →
6.
Companioni, Osmel, Sanz Anquela Jm, Eulàlia Puigdecanet, et al.. (2017). Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer. PLoS ONE. 12(4). e0176043–e0176043. 18 indexed citations
7.
Saigí, Maria, Marc Oliva, Luisa Aliste, et al.. (2017). Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre. PLoS ONE. 12(9). e0184737–e0184737. 6 indexed citations
8.
Muñoz, Xavier, Pilar Amiano, Miren Dorronsoro, et al.. (2015). Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption. Alcohol and Alcoholism. 51(3). 258–267. 7 indexed citations
9.
Peluso, Marco, Leila Luján‐Barroso, María‐José Sánchez, et al.. (2014). Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort. Carcinogenesis. 35(9). 2047–2054. 11 indexed citations
10.
Font-Ribera, Laia, Xavier Continente, Anna Pérez, et al.. (2013). Driving under the influence of alcohol or drugs among adolescents: The role of urban and rural environments. Accident Analysis & Prevention. 60. 1–4. 17 indexed citations
11.
Tàssies, Dolors, Gerard Espinosa, Begoña Hurtado, et al.. (2013). Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Research & Therapy. 15(2). R41–R41. 54 indexed citations
12.
González, Carlos A., Céu Figueiredo, Rui M. Ferreira, et al.. (2011). Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain. The American Journal of Gastroenterology. 106(5). 867–874. 110 indexed citations
13.
García, Nadia, Xavier Muñoz, Gabriel Capellá, et al.. (2010). Simultaneous Genotyping of GSTT1 and GSTM1 Null Polymorphisms by Melting Curve Analysis in Presence of SYBR Green I. Journal of Molecular Diagnostics. 12(3). 300–304. 18 indexed citations
14.
Corella, Dolores, Olga Portolés, Larraitz Arriola, et al.. (2010). Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort. The Journal of Nutritional Biochemistry. 22(5). 487–494. 29 indexed citations
15.
Hurtado, Begoña, Xavier Muñoz, Nadia García, et al.. (2010). Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. Thrombosis and Haemostasis. 104(9). 592–598. 29 indexed citations
16.
Muñoz, Xavier, Lauro Sumoy, Reposo Ramírez‐Lorca, et al.. (2004). Human vitamin K-dependentGAS6: Gene structure, allelic variation, and association with stroke. Human Mutation. 23(5). 506–512. 43 indexed citations
17.
González, Carlos A., Núria Sala, & Gabriel Capellá. (2002). Genetic susceptibility and gastric cancer risk. International Journal of Cancer. 100(3). 249–260. 268 indexed citations
18.
Mateo, José, Arturo Oliver, María Borrell, Núria Sala, & J. Fontcuberta. (1998). Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study). Blood Coagulation & Fibrinolysis. 9(1). 71–78. 34 indexed citations
19.
Borrell, M., et al.. (1995). Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias. Blood Coagulation & Fibrinolysis. 6(3). 198–206. 17 indexed citations
20.
Sala, Núria, et al.. (1993). New biological concepts on coagulation inhibitors. Intensive Care Medicine. 19(S1). S3–S7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascale Gaussem Breakdown of academic impact, for papers by Clifford M. Takemoto Breakdown of academic impact, for papers by Mark I. Furman Breakdown of academic impact, for papers by Justo Aznar Breakdown of academic impact, for papers by M Dechavanne Breakdown of academic impact, for papers by Bart J. Biemond Breakdown of academic impact, for papers by Georges E. Rivard Breakdown of academic impact, for papers by Nicole D. Zantek Breakdown of academic impact, for papers by Frederik Denorme Breakdown of academic impact, for papers by Hatem H. Salem
Rankless by CCL
2026